Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
gemcitabine (gemzar) (1 trial)
thergap-02 (1 trial)
cyl-02 (1 trial)
Adenocarcinoma (Phase 2)
Trials (2 total)
Trial APIs (3 total)